carbamazepine and ketamine

carbamazepine has been researched along with ketamine in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (42.86)29.6817
2010's8 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Hashizume, K1
Brody, SA; Geyer, MA; Large, CH; Ong, JC1
Adams, AC; Saunders, GW; Smith, MD; White, HS; Wilcox, KS1
Cunha, AO; dos Santos, WF; Liberato, JL; Mortari, MR1
Fang, MD; Jiang, JJ; Lee, CL1
Banks, A; Gao, J; Jiang, G; Lai, FY; Li, J; Mueller, JF; Thai, PK1
Davison, SN1

Reviews

2 review(s) available for carbamazepine and ketamine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[Herpes zoster and post-herpetic neuralgia].
    Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59, Issue:9

    Topics: Anticonvulsants; Antidepressive Agents, Tricyclic; Autonomic Nerve Block; Carbamazepine; Epidural Space; Herpes Zoster; Humans; Ketamine; Nerve Block; Neuralgia; Receptors, N-Methyl-D-Aspartate; Stellate Ganglion; Trigeminal Nerve

2001

Other Studies

12 other study(ies) available for carbamazepine and ketamine

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:3

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations

2002
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
An investigation of the efficacy of mood stabilizers in rodent models of prepulse inhibition.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 315, Issue:3

    Topics: Amphetamine; Anesthetics, Dissociative; Animals; Antimanic Agents; Carbamazepine; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug Interactions; Ketamine; Lithium; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Phenytoin; Reflex, Startle; Valproic Acid

2005
Phenytoin- and carbamazepine-resistant spontaneous bursting in rat entorhinal cortex is blocked by retigabine in vitro.
    Epilepsy research, 2007, Volume: 74, Issue:2-3

    Topics: Animals; Anticonvulsants; Carbamates; Carbamazepine; Cell Count; Dose-Response Relationship, Drug; Drug Resistance; Electrophysiology; Entorhinal Cortex; Epilepsy, Temporal Lobe; Evoked Potentials; Excitatory Amino Acid Antagonists; Hippocampus; Ketamine; Male; Nerve Net; Phenylenediamines; Phenytoin; Rats; Rats, Sprague-Dawley

2007
Neuroprotective effects of diazepam, carbamazepine, phenytoin and ketamine after pilocarpine-induced status epilepticus.
    Basic & clinical pharmacology & toxicology, 2009, Volume: 104, Issue:6

    Topics: Animals; Anticonvulsants; Carbamazepine; Dentate Gyrus; Diazepam; Drug Administration Schedule; Glial Fibrillary Acidic Protein; Hippocampus; Ketamine; Male; Maze Learning; Neuroprotective Agents; Phenytoin; Pilocarpine; Rats; Rats, Wistar; Status Epilepticus

2009
Emerging organic contaminants in coastal waters: anthropogenic impact, environmental release and ecological risk.
    Marine pollution bulletin, 2014, Aug-30, Volume: 85, Issue:2

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aquatic Organisms; Caffeine; Carbamazepine; Chromatography, Liquid; Environmental Monitoring; Gemfibrozil; Humans; Ketamine; N-Methyl-3,4-methylenedioxyamphetamine; Population Density; Pseudoephedrine; Risk; Rivers; Seawater; Solid Phase Extraction; Taiwan; Tandem Mass Spectrometry; Water Pollutants, Chemical

2014
Evaluation of in-sewer transformation of selected illicit drugs and pharmaceutical biomarkers.
    The Science of the total environment, 2017, Dec-31, Volume: 609

    Topics: Biofilms; Biomarkers; Carbamazepine; Codeine; Environmental Monitoring; Illicit Drugs; Ketamine; Methamphetamine; Sewage; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical

2017
Clinical Pharmacology Considerations in Pain Management in Patients with Advanced Kidney Failure.
    Clinical journal of the American Society of Nephrology : CJASN, 2019, 06-07, Volume: 14, Issue:6

    Topics: Acetaminophen; Acute Pain; Analgesics, Non-Narcotic; Analgesics, Opioid; Carbamazepine; Chronic Pain; Gabapentin; Humans; Ketamine; Kidney Failure, Chronic; Neuralgia; Nociceptive Pain; Pain Management; Renal Dialysis

2019